System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Alexandre Belot is an expert in Immunology at Hospices Civils de Lyon (France). As of October 2026, ScienceLeadR ranks Alexandre Belot in the top 1% of experts worldwide for Autoimmune Diseases, Arthritis and Coronavirus Infections. Alexandre Belot has authored 424 publications, the most recent in 2026, and is an investigator in 23 clinical trials, 8 of them ongoing. SLR score: 1,565 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Alexandre Belot Hospices Civils de Lyon France
1 565 ScienceLeadR Reputation 1565

Unlock

Register Login
Network Map

Immunology

Subspecialties: Rheumatology - Pediatrics - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2006 - 2026
Source: PubMed

Claude Bernard University Lyon 1

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 424

Citations

Citations: 18 030 1st author: 23 Last author: 66 Unique author: 11

Main journals

Rev Med Interne 32
Ann Rheum Dis 28
Rheumatology (Oxford) 19
J Exp Med 17
Joint Bone Spine 14

Best Journals

N Engl J Med 6
Nature 3
Science 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Probiotic supplementation increases fecal TLR4 agonists without improving disease activity in juvenile idiopathic arthritis: a randomized placebo-controlled trial.
PMID 42720258 — cytokines, arthritis, probiotics, therapeutics, arthritis, juvenile, immunity, innate, gastrointestinal microbiome, microbiota, child		Gut Microbes20260
Neutralizing autoantibodies against IL-1Ra in severe bacterial community-acquired pneumonia.
PMID 42695953 — autoantibodies, hypersensitivity, pneumonia, interleukin 1 receptor antagonist protein, community-acquired pneumonia		J Allergy Clin Immunol20260
A novel STAT4 gain-of-function variant defines a monogenic form of juvenile-onset systemic lupus erythematosus.
PMID 42463324 — rheumatic diseases, lupus erythematosus, systemic		Ann Rheum Dis20260
PDE4 inhibitor mitigates activated CD8+ T cells through NF-κB signaling in Behçet's syndrome.
PMID 42445175 — cells, genes, behcet syndrome, wounds and injuries, phosphodiesterase 4 inhibitors		Front Immunol20260
HSCT in SAVI: evidence for a curative hematopoietic approach and perspectives for gene therapy.
PMID 42422768 — genes, therapeutics		Mol Ther Adv20261

Clinical Studies 23

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Director: 1

By phase:

N/A 10
Phase 3 7
Phase 2 5
Phase 2/Phase 3 1

By status:

Completed 13
Recruiting 8
Not yet recruiting 1
Unknown 1

By type:

Interventional 17
Observational 6

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 3
multicentric5to9 3
multicentricup10 14

Main Topics

Cohort/Consortium Investigators 8

Ongoing Clinical Trials

8 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
An open label phase II trial to evaluate the clinical efficacy safety and tolerability of MAS825 in pediatric and adult participants with Still s disease
2024-520208-25-00 — safety		Phase 2Recruiting2026
Natural History of Type 1 Interferonopathies Insights From a European Cohort
NCT07040774 — natural history, genetics, immune system diseases, immune system, autoimmune diseases, therapeutics, nervous system, history, nervous system diseases, genetic diseases, inborn		N/ARecruiting2025
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect a Prospective National Cohort
NCT06762002 — cytokines, cells, autoantibodies, whole genome sequencing, phlebotomy, hospitalization, blood, vaccines, antibodies, immunophenotyping, hypersensitivity, neoplasms, thyroid gland, genome, vaccination, covid-19, immune system diseases, immunity, interferon type i, cell count, diagnosis, blood cells, exome, rheumatoid factor, history, communicable diseases, consent forms, genetic diseases, inborn, infections, blood cell count, plasma, virus diseases, allergy, immunology		N/ARecruiting2025
Circadian Rhythm Deregulation in Patients With CAPS
NCT06544018 — cytokines, cells, research design, blood, melatonin, blood specimen collection, circadian rhythm, heart rate, heart, urticaria, cold temperature, pyrin, inflammasomes, circadian clocks, immunity, interleukin-1, surveys and questionnaires, immunity, innate, hematologic tests, interleukin-18, pulse, cryopyrin-associated periodic syndromes, cold urticaria		N/ARecruiting2026
Biocollection of Rare Pediatric onset of Autoimmune and Autoinflammatory Diseases
NCT06435468 — dermatomyositis, research design, genetic testing, blood, blood specimen collection, immunologic factors, pathology, biomarkers, immunity, autoimmune diseases, diagnosis, research, mutation, genetic diseases, inborn, prognosis		N/ARecruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS